Dietary patterns associated with magnetic resonance imaging-determined liver fat content in a general population study1-3

American Journal of Clinical Nutrition

Volumn 99, Issue 2, 2014, Pages 369-377

  Koch, Manja ^a,b   Borggrefe, Jan ^b   Barbaresko, Janett ^d,e   Groth, Godo ^f   Jacobs, Gunnar ^a   Siegert, Sabine ^b   Lieb, Wolfgang ^a   Müller, Manfred James ^c   Bosy Westphal, Anja ^g   Heller, Martin ^f   N̈othlings, Ute ^b,d  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Experimental Medicine   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f Clinic for Diagnostic Radiology   (Germany)

^g UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGED; ARTICLE; BEER; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FAT CONTENT; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HUMAN; HYPOTHESIS; LIVER; LIVER SIGNAL INTENSITY; MAJOR CLINICAL STUDY; MALE; MEAT; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; RADIOLOGICAL PARAMETERS; SCORING SYSTEM; SOFT DRINK; TEA;

ADIPOSE TISSUE; AGED; ALCOHOL DRINKING; BODY FAT DISTRIBUTION; BODY MASS INDEX; CARBONATED BEVERAGES; CROSS-SECTIONAL STUDIES; DIET; FEMALE; FOLLOW-UP STUDIES; FOOD HABITS; HUMANS; LINEAR MODELS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEAT; MIDDLE AGED; NUTRITION ASSESSMENT; QUESTIONNAIRES; TEA;

EID: 84893349941     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.070219     Document Type: Article

References (51)

1. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: Further expression of the metabolic syndrome. J Gastroenterol Hepatol 2007;22:293-303.
2. Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10:330-44.
3. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: Old questions and new insights. Science 2011;332:1519-23.
4. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592-609.
5. Shi L, Liu ZW, Li Y, Gong C, Zhang H, Song LJ, Huang CY, Li M. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed Environ Sci 2012;25:383-91.
6. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, Oren R. Long term nutritional intake and the risk for nonalcoholic fatty liver disease (NAFLD): A population based study. J Hepatol 2007;47:711-7.
7. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005;129:1928-36.
8. Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, Yeung DK, Yiu KK, Chu SH, Woo J, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: A population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012;61:409-15.
9. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, Schnohr P, Jensen G. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology 1996; 23:1025-9.
10. Cotrim HP, Freitas LA, Alves E, Almeida A, May DS, Caldwell S. Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. Eur J Gastroenterol Hepatol 2009;21:969-72.
11. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, Grosovski M. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2008;22:811-6.
12. Gutiérrez-Grobe Y, Chavez-Tapia N, Sanchez-Valle V, Gavilanes-Espinar JG, Ponciano-Rodriguez G, Uribe M, Mendez-Sanchez N. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: The role of peripheral antioxidant activity. Ann Hepatol 2012;11:350-5.
13. Catalano D, Martines GF, Tonzuso A, Pirri C, Trovato FM, Trovato GM. Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 2010;55:3200-6.
14. Jin X, Zheng RH, Li YM. Green tea consumption and liver disease: A systematic review. Liver Int 2008;28:990-6.
15. Hu FB. Dietary pattern analysis: A new direction in nutritional epidemiology. Curr Opin Lipidol 2002;13:3-9.
16. Hoffmann K, Schulze MB, Schienkiewitz A, Nothlings U, Boeing H. Application of a new statistical method to derive dietary patterns in nutritional epidemiology. Am J Epidemiol 2004;159:935-44.
17. Oddy WH, Herbison CE, Jacoby P, Ambrosini GL, O'Sullivan TA, Ayonrinde OT, Olynyk JK, Black LJ, Beilin LJ, Mori TA, et al. The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence. Am J Gastroenterol 2013;108:778-85.
18. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-50.
19. Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102: 2708-15.
20. Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, Ratziu V, McCullough A. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 2011;54:344-53.
21. Völzke H. Multicausality in fatty liver disease: Is there a rationale to distinguish between alcoholic and non-alcoholic origin? World J Gastroenterol 2012;18:3492-501.
22. Nöthlings U, Krawczak M. [PopGen: A population-based biobank with prospective follow-up of a control group] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012;55:831-5 (in German).
23. Nöthlings U, Hoffmann K, Bergmann MM, Boeing H. Fitting portion sizes in a self-administered food frequency questionnaire. J Nutr 2007; 137:2781-6.
24. Dehne LI, Klemm C, Henseler G, Hermann-Kunz E. The German food code and nutrient data base (BLS II.2). Eur J Epidemiol 1999;15:355-9.
25. Kröger J, Ferrari P, Jenab M, Bamia C, Touvier M, Bueno-de-Mesquita HB, Fahey MT, Benetou V, Schulz M, Wirfalt E, et al. Specific food group combinations explaining the variation in intakes of nutrients and other important food components in the European Prospective Investigation into Cancer and Nutrition: An application of the reduced rank regression method. Eur J Clin Nutr 2009;63:S263-74.
26. Suijkerbuijk KP, Van Duijnhoven FJ, Van Gils CH, Van Noord PA, Peeters PH, Friedenreich CM, Monninkhof EM. Physical activity in relation to mammographic density in the dutch prospect-European prospective investigation into cancer and nutrition cohort. Cancer Epidemiol Biomarkers Prev 2006;15:456-60.
27. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, Greer JL, Vezina J, Whitt-Glover MC, Leon AS. 2011 compendium of physical activities: A second update of codes and MET values. Med Sci Sports Exerc 2011;43:1575-81.
28. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
29. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV. Accuracy of liver fat quantification at MR imaging: Comparison of outof-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 2005;237:507-11.
30. Borra RJ, Salo S, Dean K, Lautamaki R, Nuutila P, Komu M, Parkkola R. Nonalcoholic fatty liver disease: Rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology 2009;250: 130-6.
31. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012;9:671-5.
32. Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol 2009;193:14-27.
33. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: Prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288: E462-8.
34. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009;51:918-24.
35. Molloy JW, Calcagno CJ, Williams CD, Jones FJ, Torres DM, Harrison SA. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012;55:429-36.
36. Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995;310:693-6.
37. Schulze MB, Hoffmann K, Kroke A, Boeing H. An approach to construct simplified measures of dietary patterns from exploratory factor analysis. Br J Nutr 2003;89:409-19.
38. Garthwaite PH. An interpretation of partial least squares. J Am Stat Assoc 1994;89:122-7.
39. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(4 suppl):1220S-31S.
40. Mehmood T, Martens H, Saebo S, Warringer J, Snipen L. A partial least squares based algorithm for parsimonious variable selection. Algorithms Mol Biol 2011;6:27.
41. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H. Fiber and magnesium intake and incidence of type 2 diabetes: A prospective study and meta-analysis. Arch Intern Med 2007; 167:956-65.
42. Kontogianni MD, Tileli N, Margariti A, Georgoulis M, Deutsch M, Tiniakos D, Fragopoulou E, Zafiropoulou R, Manios Y, Papatheodoridis G. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr (Epub ahead of print 7 September 2013).
43. Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Gnardellis C, Lagiou P, Polychronopoulos E, Vassilakou T, Lipworth L, Trichopoulos D. Diet and overall survival in elderly people. BMJ 1995;311:1457-60.
44. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002;17:S186-90.
45. Slimani N, Fahey M, Welch AA, Wirfalt E, Stripp C, Bergstrom E, Linseisen J, Schulze MB, Bamia C, Chloptsios Y, et al. Diversity of dietary patterns observed in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr 2002;5:1311-28.
46. Nöthlings U, Boeing H, Maskarinec G, Sluik D, Teucher B, Kaaks R, Tjonneland A, Halkjaer J, Dethlefsen C, Overvad K, et al. Food intake of individuals with and without diabetes across different countries and ethnic groups. Eur J Clin Nutr 2011;65:635-41.
47. Brandstetter BR, Korfmann A, Kroke A, Becker N, Schulze MB, Boeing H. Dietary habits in the German EPIC cohorts: Food group intake estimated with the food frequency questionnaire. European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999;43:246-57.
48. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010;51:1961-71.
49. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O'Donnell CJ, Fox CS. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study. Hepatology 2010;51:1979-87.
50. Tarantino G, Capone D. Inhibition of the mTOR pathway: A possible protective role in coronary artery disease. Ann Med 2013;45:348-56.
51. Tarantino G, Caputi A. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J Gastroenterol 2011;17:3785-94.